Tag - CANTA

Developments

Cantargia reports launch of investigator-led lung cancer prevention study

Cantargia (STO: CANTA) has announced that the first patient has been dosed in a Phase 2 clinical trial investigating nadunolimab in up to 59 current or previous smokers with multifocal high-risk lung nodules, and at...

June 10, 2026

Executive Moves

Cantargia appoints Dr. Wolfram Dempke as CMO

Cantargia (Nasdaq Stockholm: CANTA) has announced the appointment of Wolfram Dempke, MD, PhD, MBA as chief medical officer (CMO), effective immediately. Dr. Morten Lind Jensen, who has served as CMO since March 2025...

October 2, 2025

Executive Moves

Cantargia names Ton Berkien as CBO

Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) announced the recruitment of Ton Berkien as Chief Business Officer effective October 1. Mr. Berkien joins the management team at Cantargia with approximately 30 years of...

June 11, 2024

Tag - CANTA

Cantargia reports launch of investigator-led lung cancer prevention study

Cantargia appoints Dr. Wolfram Dempke as CMO

Cantargia names Ton Berkien as CBO

Subscribe